vs
通用电气医疗（GEHC）与捷迈邦美（ZBH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是捷迈邦美的2.7倍（$5.7B vs $2.1B），捷迈邦美净利率更高（11.4% vs 10.3%，领先1.1%），捷迈邦美同比增速更快（9.3% vs 7.1%），过去两年通用电气医疗的营收复合增速更高（10.7% vs 3.7%）
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、核磁共振、女性健康筛查、X射线系统）、超声、患者护理解决方案（聚焦远程患者监测、麻醉呼吸护理、心脏病诊断、婴幼儿照护）及制药诊断业务。
捷迈邦美是一家美国上市的医疗设备企业，1927年成立，最初以生产铝制夹板为核心业务，总部设于印第安纳州华沙市，是当地医疗设备产业集群的核心成员，在全球骨科医疗器械领域拥有较高知名度。
GEHC vs ZBH — 直观对比
营收规模更大
GEHC
是对方的2.7倍
$2.1B
营收增速更快
ZBH
高出2.2%
7.1%
净利率更高
ZBH
高出1.1%
10.3%
两年增速更快
GEHC
近两年复合增速
3.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $5.7B | $2.1B |
| 净利润 | $588.0M | $238.3M |
| 毛利率 | 39.7% | 64.6% |
| 营业利润率 | 14.5% | 17.9% |
| 净利率 | 10.3% | 11.4% |
| 营收同比 | 7.1% | 9.3% |
| 净利润同比 | -18.4% | 30.5% |
| 每股收益（稀释后） | $1.28 | $1.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GEHCZBH
| Q1 26 | — | $2.1B | ||
| Q4 25 | $5.7B | $2.2B | ||
| Q3 25 | $5.1B | $2.0B | ||
| Q2 25 | $5.0B | $2.1B | ||
| Q1 25 | $4.8B | $1.9B | ||
| Q4 24 | $5.3B | $2.0B | ||
| Q3 24 | $4.9B | $1.8B | ||
| Q2 24 | $4.8B | $1.9B |
净利润GEHCZBH
| Q1 26 | — | $238.3M | ||
| Q4 25 | $588.0M | $139.4M | ||
| Q3 25 | $446.0M | $230.9M | ||
| Q2 25 | $486.0M | $152.8M | ||
| Q1 25 | $564.0M | $182.0M | ||
| Q4 24 | $721.0M | $239.5M | ||
| Q3 24 | $470.0M | $249.1M | ||
| Q2 24 | $428.0M | $242.8M |
毛利率GEHCZBH
| Q1 26 | — | 64.6% | ||
| Q4 25 | 39.7% | 64.7% | ||
| Q3 25 | 38.7% | 72.1% | ||
| Q2 25 | 39.6% | 71.5% | ||
| Q1 25 | 42.1% | 71.2% | ||
| Q4 24 | 42.8% | 71.0% | ||
| Q3 24 | 41.7% | 70.5% | ||
| Q2 24 | 41.4% | 71.5% |
营业利润率GEHCZBH
| Q1 26 | — | 17.9% | ||
| Q4 25 | 14.5% | 6.9% | ||
| Q3 25 | 12.7% | 17.6% | ||
| Q2 25 | 13.1% | 14.4% | ||
| Q1 25 | 13.2% | 15.3% | ||
| Q4 24 | 15.1% | 19.2% | ||
| Q3 24 | 13.9% | 15.3% | ||
| Q2 24 | 12.6% | 18.1% |
净利率GEHCZBH
| Q1 26 | — | 11.4% | ||
| Q4 25 | 10.3% | 6.2% | ||
| Q3 25 | 8.7% | 11.5% | ||
| Q2 25 | 9.7% | 7.4% | ||
| Q1 25 | 11.8% | 9.5% | ||
| Q4 24 | 13.6% | 11.8% | ||
| Q3 24 | 9.7% | 13.7% | ||
| Q2 24 | 8.8% | 12.5% |
每股收益（稀释后）GEHCZBH
| Q1 26 | — | $1.22 | ||
| Q4 25 | $1.28 | $0.71 | ||
| Q3 25 | $0.98 | $1.16 | ||
| Q2 25 | $1.06 | $0.77 | ||
| Q1 25 | $1.23 | $0.91 | ||
| Q4 24 | $1.58 | $1.18 | ||
| Q3 24 | $1.02 | $1.23 | ||
| Q2 24 | $0.93 | $1.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | $424.2M |
| 总债务越低越好 | $10.0B | $7.5B |
| 股东权益账面价值 | $10.4B | $12.7B |
| 总资产 | $36.9B | $22.7B |
| 负债/权益比越低杠杆越低 | 0.96× | 0.59× |
8季度趋势，按日历期对齐
现金及短期投资GEHCZBH
| Q1 26 | — | $424.2M | ||
| Q4 25 | $4.5B | $591.9M | ||
| Q3 25 | $4.0B | $1.3B | ||
| Q2 25 | $3.7B | $556.9M | ||
| Q1 25 | $2.5B | $1.4B | ||
| Q4 24 | $2.9B | $525.5M | ||
| Q3 24 | $3.5B | $569.0M | ||
| Q2 24 | $2.0B | $420.1M |
总债务GEHCZBH
| Q1 26 | — | $7.5B | ||
| Q4 25 | $10.0B | — | ||
| Q3 25 | $10.3B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $9.0B | — | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.2B | — |
股东权益GEHCZBH
| Q1 26 | — | $12.7B | ||
| Q4 25 | $10.4B | $12.7B | ||
| Q3 25 | $10.0B | $12.8B | ||
| Q2 25 | $9.7B | $12.5B | ||
| Q1 25 | $9.2B | $12.4B | ||
| Q4 24 | $8.4B | $12.5B | ||
| Q3 24 | $8.3B | $12.4B | ||
| Q2 24 | $7.8B | $12.7B |
总资产GEHCZBH
| Q1 26 | — | $22.7B | ||
| Q4 25 | $36.9B | $23.1B | ||
| Q3 25 | $36.1B | $23.5B | ||
| Q2 25 | $35.5B | $22.9B | ||
| Q1 25 | $33.6B | $22.2B | ||
| Q4 24 | $33.1B | $21.4B | ||
| Q3 24 | $33.9B | $21.7B | ||
| Q2 24 | $31.9B | $21.5B |
负债/权益比GEHCZBH
| Q1 26 | — | 0.59× | ||
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $359.4M |
| 自由现金流经营现金流 - 资本支出 | — | $245.9M |
| 自由现金流率自由现金流/营收 | — | 11.8% |
| 资本支出强度资本支出/营收 | 2.4% | — |
| 现金转化率经营现金流/净利润 | — | 1.51× |
| 过去12个月自由现金流最近4个季度 | — | $1.4B |
8季度趋势，按日历期对齐
经营现金流GEHCZBH
| Q1 26 | — | $359.4M | ||
| Q4 25 | — | $517.4M | ||
| Q3 25 | — | $418.7M | ||
| Q2 25 | $94.0M | $378.2M | ||
| Q1 25 | $250.0M | $382.8M | ||
| Q4 24 | — | $506.3M | ||
| Q3 24 | — | $395.7M | ||
| Q2 24 | $-119.0M | $369.4M |
自由现金流GEHCZBH
| Q1 26 | — | $245.9M | ||
| Q4 25 | — | $442.6M | ||
| Q3 25 | — | $363.7M | ||
| Q2 25 | $8.0M | $328.1M | ||
| Q1 25 | $98.0M | $338.2M | ||
| Q4 24 | — | $454.8M | ||
| Q3 24 | — | $351.2M | ||
| Q2 24 | $-183.0M | $316.7M |
自由现金流率GEHCZBH
| Q1 26 | — | 11.8% | ||
| Q4 25 | — | 19.7% | ||
| Q3 25 | — | 18.2% | ||
| Q2 25 | 0.2% | 15.8% | ||
| Q1 25 | 2.1% | 17.7% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 19.3% | ||
| Q2 24 | -3.8% | 16.3% |
资本支出强度GEHCZBH
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 3.3% | ||
| Q3 25 | 2.1% | 2.7% | ||
| Q2 25 | 1.7% | 2.4% | ||
| Q1 25 | 3.2% | 2.3% | ||
| Q4 24 | 1.9% | 2.5% | ||
| Q3 24 | 1.9% | 2.4% | ||
| Q2 24 | 1.3% | 2.7% |
现金转化率GEHCZBH
| Q1 26 | — | 1.51× | ||
| Q4 25 | — | 3.71× | ||
| Q3 25 | — | 1.81× | ||
| Q2 25 | 0.19× | 2.48× | ||
| Q1 25 | 0.44× | 2.10× | ||
| Q4 24 | — | 2.11× | ||
| Q3 24 | — | 1.59× | ||
| Q2 24 | -0.28× | 1.52× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
ZBH
暂无分部数据
